Figure 1 (Progesterone Fig1)
Progesterone Capsule
Product Images NDC 59651-152
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Progesterone (NDC 59651-152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Package Label-principal Display Panel (100 mg (100 Capsules Bottle))
This is a description for Progesterone Capsules, containing 100 mg microrized progesterone USP. It contains USPANF-defined storage instructions, possible dosage instructions and a seal requirement. It should not be used if allergic to peanuts, and should be dispensed as defined. It is distributed by Aurobinde Pharma USA, Inc., and is manufactured in India. There are also some additional markings and codes printed which are not part of the description.*
Package Label-principal Display Panel (200 mg (100 Capsules Bottle))
Chemical Structure (Progesterone Str)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
